72% de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor. Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento. 72% de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor. Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Inicio・Lista de Acciones・Abbott Laboratories

Search

Abbott Laboratories

Cerrado

SectorSanidad

84.43 -0.51

Resumen

Variación precio

24h

Actual

Mínimo

84.12

Máximo

86.06

Métricas clave
By Trading Economics
Ingresos	-699M 1.1B
Ventas	-295M 11B
P/B Media del Sector	23.126 51.415
BPA	1.15
Rentabilidad por dividendo	2.89
Margen de beneficios	9.647
Empleados	122,000
EBITDA	-980M 1.8B

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+41.63% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	2.89% 2.34%
Próximas Ganancias	16 jul 2026
Próxima Fecha de Ex Dividendo	14 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-31B 144B
Apertura anterior	84.94
Cierre anterior	84.43

Noticias sobre sentimiento de mercado

By Acuity

41%

59%

131 / 345 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

132.82 / 134.43 Soporte y Resistencia

Abbott Laboratories Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 abr 2026, 15:13 UTC

Ganancias

Principales Movimientos del Mercado

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16 abr 2026, 12:23 UTC

Ganancias

Principales Movimientos del Mercado

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22 ene 2026, 18:36 UTC

Ganancias

Principales Movimientos del Mercado

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

22 ene 2026, 13:23 UTC

Ganancias

Principales Movimientos del Mercado

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

16 abr 2026, 20:23 UTC

Ganancias

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 abr 2026, 16:15 UTC

Ganancias

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 abr 2026, 14:00 UTC

Charlas de Mercado

Ganancias

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16 abr 2026, 13:59 UTC

Charlas de Mercado

Ganancias

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16 abr 2026, 12:05 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16 abr 2026, 11:32 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs 1Q Sales $11.16B >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs 1Q Net $1.08B >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs 1Q Adj EPS $1.15 >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16 abr 2026, 11:30 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Abbott Labs 1Q EPS 61c >ABT

11 abr 2026, 00:00 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Big Yachts, Big Bucks -- Barrons.com

23 mar 2026, 12:50 UTC

Adquisiciones, fusiones, absorciones

Abbott Completes Acquisition Of Exact Sciences >ABT

20 mar 2026, 13:01 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20 mar 2026, 13:00 UTC

Adquisiciones, fusiones, absorciones

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28 ene 2026, 14:48 UTC

Ganancias

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23 ene 2026, 16:59 UTC

Ganancias

Correction to Abbott Stock Drops Article on Jan. 22

22 ene 2026, 20:42 UTC

Ganancias

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 ene 2026, 16:19 UTC

Ganancias

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 ene 2026, 15:22 UTC

Ganancias

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22 ene 2026, 14:41 UTC

Acciones populares

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22 ene 2026, 14:08 UTC

Charlas de Mercado

Ganancias

Abbott Posts Disappointing 4Q -- Market Talk

Comparación entre iguales

Cambio de precio

Abbott Laboratories previsión

Precio Objetivo

By TipRanks

41.63% repunte

Estimación a 12 Meses

Media 120.24 USD 41.63%

Máximo 143 USD

Mínimo 92 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

20 ratings

16

Comprar

4

Mantener

0

Vender

De acuerdo con 20 analistas que ofrecen calificaciones bursátiles a para Abbott Laboratories Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

132.82 / 134.43Soporte y Resistencia

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bullish.

Sentimiento

By Acuity

131 / 345 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Otras acciones del sector

LLY

Eli Lilly and Co.

1,004

JNJ

Johnson and Johnson

226.76

ABBV

AbbVie Inc

210.42

UNH

UnitedHealth Group Inc

393.66

AZN

AstraZeneca PLC

181.62